Serum Institute of India seeks regular marketing authorisation from DCGI for Covishield
newsdepo.com
The Pune-based SII has submitted the final phase 2/3 clinical study report of India with its application for grant of regular market authorization for Covishield, an official source said.Serum Institute of India seeks regular marketing authorisation from DCGI for Covishield
The Pune-based SII has submitted the final phase 2/3 clinical study report of India with its application for grant of regular market authorization for Covishield, an official source said. Read more
